Health care quality

CHESS Health Selected for Nationwide NIDA Study on Medication for Opioid Use Disorder

Retrieved on: 
Thursday, July 23, 2020

Patients stable on medication and who wish to taper and, ultimately, discontinue medication will be randomized to receive CHESS' evidence-based Connections App plus medical management or medical management alone.

Key Points: 
  • Patients stable on medication and who wish to taper and, ultimately, discontinue medication will be randomized to receive CHESS' evidence-based Connections App plus medical management or medical management alone.
  • The study will measure the difference in successful discontinuation from medication without relapse to opioid use with and without the Connections App.
  • "This national study is incredibly important in testing strategies for medication adherence and discontinuation," said Hans Morefield, chief executive officer of CHESS Health.
  • We are thrilled that CHESS Health has partnered with us to provide their innovative eRecovery app to our participants."

Komodo Health Lauded by Frost & Sullivan for Empowering Healthcare Stakeholders with Dynamic Real-world Evidence Solutions

Retrieved on: 
Thursday, July 23, 2020

"Komodo differentiates itself with its data expertise, digital technology capability, and focus on delivering value for the customer," said Koustav ChatterjeePrincipal Analyst.

Key Points: 
  • "Komodo differentiates itself with its data expertise, digital technology capability, and focus on delivering value for the customer," said Koustav ChatterjeePrincipal Analyst.
  • Komodo's robust spectrum of software solutions include Aperture, Pulse, and Prism, which are all built on the company's Healthcare Map.
  • Komodo partners with Datavant to expand its Healthcare Map further and to connect thousands of de-identified patient datasets.
  • As a result, we empower a multitude of healthcare stakeholders life science companies, healthcare payers and providers, patient advocacy groups, and others to create a more cost-effective, value-driven healthcare system.

Komodo Health Lauded by Frost & Sullivan for Empowering Healthcare Stakeholders with Dynamic Real-world Evidence Solutions

Retrieved on: 
Thursday, July 23, 2020

"Komodo differentiates itself with its data expertise, digital technology capability, and focus on delivering value for the customer," said Koustav ChatterjeePrincipal Analyst.

Key Points: 
  • "Komodo differentiates itself with its data expertise, digital technology capability, and focus on delivering value for the customer," said Koustav ChatterjeePrincipal Analyst.
  • Komodo's robust spectrum of software solutions include Aperture, Pulse, and Prism, which are all built on the company's Healthcare Map.
  • Komodo partners with Datavant to expand its Healthcare Map further and to connect thousands of de-identified patient datasets.
  • As a result, we empower a multitude of healthcare stakeholders life science companies, healthcare payers and providers, patient advocacy groups, and others to create a more cost-effective, value-driven healthcare system.

With 101 Days to Compliance Deadline, The Sequoia Project Announces Anti-Information Blocking Support for Healthcare and Health IT Communities

Retrieved on: 
Thursday, July 23, 2020

The program includes a 13-week Information Blocking Compliance Boot Camp and a free public resource center .

Key Points: 
  • The program includes a 13-week Information Blocking Compliance Boot Camp and a free public resource center .
  • The new, web-based Information Blocking Compliance Resource Center features dozens of free tools, checklists, reports and webinars from The Sequoia Project and its partners.
  • The boot camp provides the opportunity for participants to engage each other in discussing the information blocking rule and compliance.
  • The Sequoia Project is a non-profit, 501c3, public-private collaborative chartered to advance implementation of secure, interoperable nationwide health information exchange.

NCQA Selects Apervita as Beta Partner for eCQM Certification Program

Retrieved on: 
Thursday, July 23, 2020

CHICAGO, July 23, 2020 /PRNewswire/ -- Apervita , a trusted technology leader in healthcare collaboration for payers, providers, and other stakeholders, today announced that it has been named a beta testing partner for the National Committee for Quality Assurance (NCQA) eCQM Certification Program.

Key Points: 
  • CHICAGO, July 23, 2020 /PRNewswire/ -- Apervita , a trusted technology leader in healthcare collaboration for payers, providers, and other stakeholders, today announced that it has been named a beta testing partner for the National Committee for Quality Assurance (NCQA) eCQM Certification Program.
  • Apervita was selected for this program as a result of their performance, technical capabilities and for meeting criteria set forth by the NCQA.
  • The goal of NCQA's beta testing program is a more robust, efficient eCQM certification process for NCQA to provide to the healthcare industry.
  • "Being handpicked to be part of the NCQA beta testing vendor program is a distinct honor for Apervita.

EVERSANA's Data & Analytics platform to be used by ICER to conduct indirect treatment comparisons to support value assessments

Retrieved on: 
Thursday, July 23, 2020

ICER will useEVERSANA's proprietary technology as the preferred platform for conducting indirect treatment comparisons to obtain comparative effectiveness data in the absence of head-to-head clinical trials.

Key Points: 
  • ICER will useEVERSANA's proprietary technology as the preferred platform for conducting indirect treatment comparisons to obtain comparative effectiveness data in the absence of head-to-head clinical trials.
  • The organization began testing EVERSANA's data analytics and evidence synthesis platform in early 2020.
  • In late 2019, EVERSANA acquired Canada-based Cornerstone Research Group, a leader in indirect treatment comparisons and HEOR services.
  • "EVERSANA's platform will make us more efficient in how we conduct high-quality and reproducible indirect treatment comparisons," saidFoluso Agboola, MBBS, MPH,Director of Evidence Synthesis for ICER.

Study finds HFCWO Therapy using Philips InCourage System reduces hospitalizations

Retrieved on: 
Thursday, July 23, 2020

The study examined data from a registry of adult bronchiectasis patients self-reported outcomes collected by RespirTech, a Philips company.

Key Points: 
  • The study examined data from a registry of adult bronchiectasis patients self-reported outcomes collected by RespirTech, a Philips company.
  • As an added benefit beyond the results of the study, the Philips InCourage System is uniquely supported by patient-centric services designed to optimize product use, improve patient-provider communication, and encourage therapy adherence.
  • This study shows positive results that HFCWO therapy delivered by the InCourage system, coupled with RespirTechs patient-centered service model, can help to reduce hospitalizations and antibiotic use for chronic respiratory patients, while also improving their overall quality of life.
  • To learn more about Philips InCourage system and airway clearance solutions including RespirTech patient services, please visit www.RespirTech.com .

Qualtrics Receives HCAHPS Approval

Retrieved on: 
Thursday, July 23, 2020

Hospitals can now view their HCAHPS results alongside their real-time data in the Qualtrics XM Platform, powering fast response to insights and identifying ways to improve the patient experience on a single platform.

Key Points: 
  • Hospitals can now view their HCAHPS results alongside their real-time data in the Qualtrics XM Platform, powering fast response to insights and identifying ways to improve the patient experience on a single platform.
  • With HCAHPS approval for both mail and phone modes, customers can now leverage the Qualtrics platform for both their required regulatory surveys and real-time patient feedback.
  • This will not only identify ways to improve HCAHPS scores, but help customers focus on taking action immediately to deliver the best possible patient experience," said Patty Riskind, Head of Global Healthcare, Qualtrics.
  • To learn more about Qualtrics and HCAHPS, visit this page .

United States Medical Peer/External Physician Review Services Market to 2030 - Industry Analysis and Growth Forecast - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 23, 2020

The "U.S. Medical Peer/External Physician Review Services Market Research Report: By Provider - Global Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "U.S. Medical Peer/External Physician Review Services Market Research Report: By Provider - Global Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
  • The presence of clear guidelines regarding external physician/ medical peer review services in the U.S. is another major factor boosting the adoption of these services in the country.
  • Medical peer review and external physician review services are mainly provided by the medical universities and academic institutes, certified physicians, medical professional societies, peer review organizations (PROs), and law and consulting firms/organizations.
  • One of the major trends currently being observed in the U.S. medical peer/external physician review services market is the surging number of acquisitions amongst the various medical peer review service providing companies all around the world.

Medline Announces 2020 Community Impact Grant Program to Help Stimulate Health Equity

Retrieved on: 
Wednesday, July 22, 2020

NORTHFIELD, Ill., July 22, 2020 /PRNewswire/ --Vulnerable communities impacted by health inequities could soon receive funding to help improve population health through a Medline Community Impact Grant program announced today.

Key Points: 
  • NORTHFIELD, Ill., July 22, 2020 /PRNewswire/ --Vulnerable communities impacted by health inequities could soon receive funding to help improve population health through a Medline Community Impact Grant program announced today.
  • Through August 31, non-profit organizations can visit the Community Impact Grant Program page to submit an application.
  • To qualify, applications for the Community Impact Grant Program must address one of the following healthcare challenges: breast cancer awareness, heart disease, or population health.
  • 2020 marks the third year of the Community Impact Grant Program to provide financial support to non-profit organizations committed to improving the well-being of communities across the countries.